ResearcherTehran University of Medical SciencesNo recent work listed
Seyed Hamidollah Ghaffari
Matched on ORCID iD 0000-0002-8633-9077; OpenAlex author ID A5066883249. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 1
2019: 1 paper · 2020: 1 paper
Papers 2
- Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells. Last author DOI 10.1007/s13402-019-00473-9↗
- The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells. Last author DOI 10.1007/s13402-019-00448-w↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Majid Momeny · 2 shared papers, 2019–2020 · strength 0.19
- Paper Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal ade… DOI 10.1007/s13402-019-00473-9↗
- Paper The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells. DOI 10.1007/s13402-019-00448-w↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.